Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis

ClinicalTrials.gov ID: NCT04072822

Public ClinicalTrials.gov record NCT04072822. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 4:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double Blinded, Placebo-controlled Clinical Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis by the AlcHepNet Consortium

Study identification

NCT ID
NCT04072822
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Indiana University
Other
Enrollment
147 participants

Conditions and interventions

Interventions

  • Anakinra and Zinc Drug
  • Placebos Drug
  • Prednisone Drug

Drug

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 9, 2020
Primary completion
May 23, 2022
Completion
Aug 11, 2022
Last update posted
Feb 9, 2025

2020 – 2022

United States locations

U.S. sites
10
U.S. states
10
U.S. cities
10
Facility City State ZIP Site status
Mayo Clinic Phoenix Arizona 85054
Mayo Clinic Jacksonville Florida 32224
Indiana Universtiy Indianapolis Indiana 46202-2879
University of Louisville Louisville Kentucky 40292
Beth Israel Deaconess Medical Center Boston Massachusetts 01003
Mayo Clinic Rochester Minnesota 55902
Cleveland Clinic Cleveland Ohio 44195
University of Pittsburgh Pittsburgh Pennsylvania 15260
University of Texas Southwestern Medical School Dallas Texas 75390
Virginia Commonwealth University Richmond Virginia 23284

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04072822, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 9, 2025 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04072822 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →